Based on 2 analysts offering 12 month price targets for Eloxx Pharmaceuticals Inc
Min Forecast
$40.00+212.26%
Avg Forecast
$41.50+223.97%
Max Forecast
$43.00+235.68%
Should I buy or sell ELOX stock?
Based on 2 analysts offering ratings for Eloxx Pharmaceuticals Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ELOX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ELOX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More
Be the first to know when Wall Street analysts revise their ELOX stock forecasts and price targets.
ELOX stock forecasts by analyst
Analyst / Firm
Rating
Action
Price Target
Upside/Downside
Date
Analyst Color
locked
locked
$00.00
+00.00%
2026-07-22
locked
locked
$00.00
+00.00%
2026-07-20
1 of 1
Forecast return on equity
Is ELOX forecast to generate an efficient return?
Insufficient data to display
Forecast return on assets
Is ELOX forecast to generate an efficient return on assets?
Is Eloxx Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: ELOX) stock is to Strong Buy ELOX stock.
Out of 2 analysts, 1 (50%) are recommending ELOX as a Strong Buy, 1 (50%) are recommending ELOX as a Buy, 0 (0%) are recommending ELOX as a Hold, 0 (0%) are recommending ELOX as a Sell, and 0 (0%) are recommending ELOX as a Strong Sell.
What is ELOX's earnings growth forecast for 2026-2026?
(NASDAQ: ELOX) Eloxx Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Eloxx Pharmaceuticals's earnings in 2026 is N/A.
In 2026, ELOX is forecast to generate -$9,499,255 in earnings, with the lowest earnings forecast at -$9,126,735 and the highest earnings forecast at -$9,778,645.
What is ELOX's revenue growth forecast for 2026-2026?
(NASDAQ: ELOX) Eloxx Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Eloxx Pharmaceuticals's revenue in 2026 is N/A.
In 2026, ELOX is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.
What is ELOX's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: ELOX) forecast ROA is -111.72%, which is lower than the forecast US Biotechnology industry average of -19.78%.
What is ELOX's Price Target?
According to 2 Wall Street analysts that have issued a 1 year ELOX price target, the average ELOX price target is $41.50, with the highest ELOX stock price forecast at $43.00 and the lowest ELOX stock price forecast at $40.00.
On average, Wall Street analysts predict that Eloxx Pharmaceuticals's share price could reach $41.50 by Jul 22, 2027. The average Eloxx Pharmaceuticals stock price prediction forecasts a potential upside of 223.97% from the current ELOX share price of $12.81.
What is ELOX's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: ELOX) Eloxx Pharmaceuticals's current Earnings Per Share (EPS) is N/A. In 2026, ELOX's EPS is forecast to hit -$8.00 (min: -$7.68, max: -$8.23).
What is ELOX's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: ELOX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.